Merrimack Pharmaceuticals (United States)

276 papers and 8.2k indexed citations i.

About

In recent decades, authors affiliated with Merrimack Pharmaceuticals (United States) have published 276 papers, which have received a total of 8.2k indexed citations. Scholars at this organization have produced 148 papers in Oncology, 109 papers in Molecular Biology and 95 papers in Radiology, Nuclear Medicine and Imaging on the topics of HER2/EGFR in Cancer Research (84 papers), Monoclonal and Polyclonal Antibodies Research (79 papers) and Nanoparticle-Based Drug Delivery (33 papers). Their work is cited by papers focused on Molecular Biology (4.8k citations), Oncology (2.7k citations) and Radiology, Nuclear Medicine and Imaging (1.9k citations). Authors at Merrimack Pharmaceuticals (United States) collaborate with scholars in United States, Germany and Spain and have published in prestigious journals including Cell, Proceedings of the National Academy of Sciences and Nature Communications. Some of Merrimack Pharmaceuticals (United States)'s most productive authors include Birgit Schoeberl, Ulrik B. Nielsen, Bart S. Hendriks, Daryl C. Drummond and Jonathan B. Fitzgerald.

In The Last Decade

Fields of papers published by authors at Merrimack Pharmaceuticals (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Merrimack Pharmaceuticals (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Merrimack Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Merrimack Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Merrimack Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merrimack Pharmaceuticals (United States) more than expected).

Rankless by CCL
2025